| FDA | Food and Drug Administration |
| CVDs | Cardiovascular diseases |
| ELIS | Enzyme linked immunosorbent assay |
| PGE1 | Prostaglandin E1 |
| HEPES | [N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid] |
| PRP | Platelet-rich plasma |
| IgG | Immunoglobulin G |
| BSA | Albumin bovine serum |
| PE | P-phycoerythrin |
| FITC | Fluorescein isothiocyanate |
| HPLC | High performance liquid chromatography |
| ESI | Electrospray ionization |
| SRM | Selected reaction monitoring |
| VWF | Von Willebrand factor |
| PCI | Percutaneous coronary intervention |